background image

Clinical Trials In Quebec

Discover hundreds of clinical trials in Quebec.
Search clinical trials in Quebec by city, condition or phase.

Filter
1

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Montreal, Greenfield Park, Ottawa, Quebecshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Recruiting
PHASE3

Sponsor:

Ontario Clinical Oncology Group (OCOG)

Location:

Sherbrooke, Montreal, Levis, Quebec Cityshow 13 more

Code:

NCT04228991

Conditions

Breast Neoplasms

Radiotherapy

Lymphedema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Locoregional radiation treatment - Conventional fractionation

Locoregional radiation treatment - Hypofractionation

EPI-STORM: Cytokine Storm in Organ Donors

Recruiting

Sponsor:

Université de Sherbrooke

Location:

Sherbrooke, Montreal, Quebec city

Code:

NCT03786991

Conditions

Organ Donation

Liver Transplantation

Kidney Transplantation

Graft Dysfunction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

No intervention

Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)

Recruiting

Sponsor:

Université de Sherbrooke

Location:

Sherbrooke

Code:

NCT05968391

Conditions

Kidney Failure, Chronic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PET scan metabolic day

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Montreal, Ottawa, Rochester, Baltimoreshow 12 more

Code:

NCT04635891

Conditions

FSHD

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Victoriaville, Trois-Rivieres, Quebec, Saint-Charles-Borromeeshow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

Preoperative Glucose Infusion: a Novel Strategy to Improve Liver Function After Liver Resection

Recruiting

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Location:

Montreal

Code:

NCT00623662

Conditions

Hepatic Insufficiency

Liver Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Preoperative glucose infusion

Preoperative normal saline infusion

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Recruiting
PHASE1

Sponsor:

Seagen Inc.

Location:

Montreal, Toronto, Cleveland, Fairfaxshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

Airway Inflammation and Disease Burden in Asthmatic Smokers

Recruiting

Sponsor:

Université de Montréal

Location:

Montreal

Code:

NCT02833727

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Smoking

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Recruiting
PHASE3

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Location:

Montreal, Toronto, Philadelphia, Pittsburghshow 3 more

Code:

NCT04935476

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Dapsone 85 mg PO BID

Placebo 85 mg PO BID

Popular cities in Quebec